Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia 30Neoplasms 21Febrile Neutropenia 19Venous Thromboembolism 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neutropenia 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Pulmonary Embolism 4Myelodysplastic Syndromes 4Leukemia 4Fever 4Anemia, Iron-Deficiency 4Venous Thrombosis 3Thrombocytopenia 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Vitamin D Deficiency 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sepsis 2Recurrence 2Postoperative Complications 2Lymphoma, Follicular 2Lymphoma 2Infections 2

Interventions

apixaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Catheter-Related Infections × Classical hematology × Clear all
NCT06603870 2025-05-30

STREAM-Line

Ottawa Hospital Research Institute

Phase 4 Recruiting
330 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡